[go: up one dir, main page]

DE4320117A1 - Combination products - Google Patents

Combination products

Info

Publication number
DE4320117A1
DE4320117A1 DE19934320117 DE4320117A DE4320117A1 DE 4320117 A1 DE4320117 A1 DE 4320117A1 DE 19934320117 DE19934320117 DE 19934320117 DE 4320117 A DE4320117 A DE 4320117A DE 4320117 A1 DE4320117 A1 DE 4320117A1
Authority
DE
Germany
Prior art keywords
metabolites
indications
main
still
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19934320117
Other languages
German (de)
Inventor
Margarethe Rabien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE19924201196 priority Critical patent/DE4201196C2/en
Priority claimed from DE19924201196 external-priority patent/DE4201196C2/en
Application filed by Individual filed Critical Individual
Priority to DE19934320117 priority patent/DE4320117A1/en
Publication of DE4320117A1 publication Critical patent/DE4320117A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Published without abstract.

Description

Die Kombinationspräparate bestehen zumindest aus α-Lipon­ säure und oder ihrer Abkömmlinge und oder ihrer Bestand­ teile und oder ihrer Metabolite und Pantethensäure (bzw. Dexpanthenol) und oder ihrer Abkömmlinge und oder ihrer Bestandteile und oder ihrer Metabolite.The combination preparations consist at least of α-lipon acid and or its descendants and or its stock parts and or their metabolites and pantethenic acid (or Dexpanthenol) and or their descendants and or their Ingredients and or their metabolites.

Sie sind insbesondere zur Behandlung von den verschiedens­ ten neurologischen Indikationen (s. Hauptanmeldung) und Hautindikationen (s. Zusatzanmeldung (P 43 13 428.9) usw. geeignet. Sie sollen aber auch für jede weitere Indikation, die eventuell noch möglich ist, abgedeckt sein.They are especially used to treat the various neurological indications (see main registration) and Skin indications (see additional registration (P 43 13 428.9) etc. suitable. But they should also be used for any other indication, that may still be possible.

Die Kombinationspräparate gemäß den Ansprüchen in der Haupt- und in den Zusatzanmeldungen können auch oder an Stelle der B-Vitamine deren Abkömmlinge, deren Bestandteile oder deren Metabolite enthalten. Auch alle Abkömmlinge von Vitamin E, dessen Bestandteile und oder dessen Metabolite können darin vorkommen. Auch andere Substanzen können darin vorkommen.The combination preparations according to the claims in the main and in the additional applications can also or instead of B vitamins their descendants, their components or their Metabolites included. Also all descendants of vitamin E, its constituents and or its metabolites can therein occurrence. Other substances can also be found in it.

Sämtliche Ansprüche in der Haupt- und in den Zusatzanmel­ dungen sollen für Lebererkrankungen und für jede weitere Indikation, die eventuell noch möglich ist, abgedeckt sein und natürlich für die bereits genannten Indikationen un­ abhängig davon, was man noch dazu mixt.All claims in the main and additional applications are intended for liver diseases and for every further Indication that may still be possible and of course for the indications already mentioned depending on what you mix.

Claims (4)

1. Kombinationspräparate nach Patentanmeldung 42 01 196.5, dadurch gekennzeichnet, daß sie zumindest aus α-Lipon­ säure und oder ihrer Abkömmlinge und oder ihrer Bestand­ teile und oder ihrer Metabolite und Pantothensäure (bzw. Dexpanthenol) und oder ihrer Abkömmlinge und oder ihrer Bestandteile und oder ihrer Metabolite bestehen.1. Combination preparations according to patent application 42 01 196.5, characterized in that they share at least from α-lipoic acid and or its derivatives and or its constituent and or its metabolites and pantothenic acid (or dexpanthenol) and or its derivatives and or its constituents and or of their metabolites exist. Sie sind insbesondere zur Behandlung von den ver­ schiedensten neurologischen Indikationen (s. Hauptan­ meldung) und Hautindikationen (s. Zusatzanmeldung (P 43 13 428.9) usw. geeignet. Sie sollen aber auch für jede weitere Indikation, die eventuell noch möglich ist, abgedeckt sein.They are particularly used to treat ver various neurological indications (see Hauptan notification) and skin indications (see additional registration (P 43 13 428.9) etc. But you should also for any further indication that may still be possible be covered. 2. Kombinationspräparate gemäß den Ansprüchen in der Haupt- und in den Zusatzanmeldungen, die auch oder an Stelle der B-Vitamine deren Abkömmlinge, deren Bestandteile oder deren Metabolite enthalten können. Auch alle Ab­ kömmlinge von Vitamin E, dessen Bestandteile und oder dessen Metabolite können darin vorkommen. Auch andere Substanzen können darin vorkommen.2. Combination preparations according to the claims in the main and in the additional applications, also or in place of the B vitamins their descendants, their components or may contain their metabolites. All ab comers of vitamin E, its components and or its metabolites can occur in it. Others too Substances can appear in it. Sämtliche Ansprüche in der Haupt- und in den Zusatzan­ meldungen sollen für Lebererkrankungen und für jede weitere Indikation, die eventuell noch möglich ist, ab­ gedeckt sein und natürlich für die bereits genannten Indikationen unabhängig davon, was man noch dazu mixt.All claims in the main and additional reports should be for liver diseases and for everyone further indication, which may still be possible be covered and of course for those already mentioned Indications regardless of what you mix.
DE19934320117 1992-01-18 1993-06-18 Combination products Withdrawn DE4320117A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE19924201196 DE4201196C2 (en) 1992-01-18 1992-01-18 Medicines used to treat polyneuropathy
DE19934320117 DE4320117A1 (en) 1992-01-18 1993-06-18 Combination products

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19924201196 DE4201196C2 (en) 1992-01-18 1992-01-18 Medicines used to treat polyneuropathy
DE19934320117 DE4320117A1 (en) 1992-01-18 1993-06-18 Combination products

Publications (1)

Publication Number Publication Date
DE4320117A1 true DE4320117A1 (en) 1994-12-22

Family

ID=25911055

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19934320117 Withdrawn DE4320117A1 (en) 1992-01-18 1993-06-18 Combination products

Country Status (1)

Country Link
DE (1) DE4320117A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3802895A1 (en) * 1988-02-01 1989-08-10 Koeltringer Peter Combination product for the treatment of disorders and injuries of nerve cells and nerve fibres
DE4035456A1 (en) * 1989-11-09 1991-05-16 Asta Pharma Ag Pharmaceutical composition
DE9200543U1 (en) * 1992-01-18 1992-05-07 Rabien, Margarethe, 65239 Hochheim Ataxia medication in which a-lipoic acid + pantothenic acid or dexpanthenol are combined (also against MS, muscular atrophy, polyneuropathy, etc.)
DE4201196A1 (en) * 1992-01-18 1993-08-12 Rabien Margarethe Use of multi component compsn. contg. alpha lipoic acid and vitamin(s)
DE4218572A1 (en) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistic combination of drugs containing as active ingredient alpha-lipoic acid, dihydrolipoic acid, their metabolites as well as the oxidized and reduced enantiomers of alpha-lipoic acid such as R-alpha-lipoic acid or S-alpha-lipoic acid and metabolites of alpha-lipoic acid with vitamins A, B1 -6, B12, C and E

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3802895A1 (en) * 1988-02-01 1989-08-10 Koeltringer Peter Combination product for the treatment of disorders and injuries of nerve cells and nerve fibres
DE4035456A1 (en) * 1989-11-09 1991-05-16 Asta Pharma Ag Pharmaceutical composition
DE9200543U1 (en) * 1992-01-18 1992-05-07 Rabien, Margarethe, 65239 Hochheim Ataxia medication in which a-lipoic acid + pantothenic acid or dexpanthenol are combined (also against MS, muscular atrophy, polyneuropathy, etc.)
DE4201196A1 (en) * 1992-01-18 1993-08-12 Rabien Margarethe Use of multi component compsn. contg. alpha lipoic acid and vitamin(s)
DE4218572A1 (en) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistic combination of drugs containing as active ingredient alpha-lipoic acid, dihydrolipoic acid, their metabolites as well as the oxidized and reduced enantiomers of alpha-lipoic acid such as R-alpha-lipoic acid or S-alpha-lipoic acid and metabolites of alpha-lipoic acid with vitamins A, B1 -6, B12, C and E

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Chemical-Abstracts: Vol.109,1988,Ref.209980h *
Derwent-Abstracts, Ref.87-255392/36 *
Vol. 79,1973,Ref.135593x *
Vol. 83,1975,Ref. 523m *
Vol. 90,1979,Ref.166927r *
Vol.108,1988,Ref.220675n *

Similar Documents

Publication Publication Date Title
DE59906017D1 (en) BENZOCYCLOHEPTENE, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS THAT CONTAIN AND THE USE THEREOF FOR THE PRODUCTION OF MEDICINAL PRODUCTS
EP0230209A3 (en) Microbicides
DE69311541D1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING THE DEACYLATED GLYCEROPHOSPHOLIPIDES
DE69531722D1 (en) Carcinostatic compositions containing cis-oxaliplatin and one or more other compatible carcinostats
DE4320117A1 (en) Combination products
DE4321957C2 (en) Use of a hormonal agent to treat acne
DE69809435T2 (en) INHIBITOR AND PRESERVATIVE COMPOSITION
CH676424A5 (en)
AT399504B (en) NEW AMINOPROPOXYIMINO CYCLOAL CANDERIVATIVES, THEIR PRODUCTION, MEDICINAL PRODUCTS THAT CONTAIN THESE COMPOUNDS AS AN ACTIVE SUBSTANCE AND METHOD FOR THE PRODUCTION THEREOF
EP0362471A1 (en) Prophylactic for fish
Hartung Sprachliche Kommunikation und Linguistik. Offene Fragen einer kommunikationsorientierten Linguistik
DE2338323A1 (en) ANTISEPTIC MEDIUM
DE3889895T2 (en) Toothpaste with clay.
Albrecht et al. The conferences of the German Society of Legal Medicine in the mirror of history
EP0385369A2 (en) Method for the antimicrobiol preservation of surfactant
WO1998023245A2 (en) Preservative containing 1,6-hexanediol
Ernst Umweltwandel und Allmende-Problematik
Heß Landes-und Raumforschung in der Zeit des Nationalsozialismus.: Die Leipziger Hochschularbeitsgemeinschaften für Raumforschung (1939–1945/46)
Gudelj SIEZEN UND DUZEN IM GESCHÄFTLICHEN UMFELD–BEISPIELE AUS KROATIEN UND DEUTSCHLAND
WO2000030631A1 (en) Use of diminazene-di-aceturate for treating malaria
Howanitz et al. Ich-Splitter.(Cross-) Mediale Selbstentwürfe in den slawischen Kulturen.
Wöhlken et al. Nachfrage nach Geflügelfleisch in der BR Deutschland
Pisk Regnum Sclavoniae
Becker Herkunft, Qualität und regionales Marketing
Bächtold Zur Aus-und Weiterbildung in Raumplanung: Ergebnisse einer Umfrage bei den schweizerischen Raumplanungsfachstellen

Legal Events

Date Code Title Description
AF Is addition to no.

Ref country code: DE

Ref document number: 4201196

Format of ref document f/p: P

OM8 Search report available as to paragraph 43 lit. 1 sentence 1 patent law
AF Is addition to no.

Ref country code: DE

Ref document number: 4201196

Format of ref document f/p: P

8141 Disposal/no request for examination